Hezhi Fang

11PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsPhotovoltaic power systemsMedical biochemistry - inorganic elements and compoundsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 30, 2026
Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer.

|Nov 05, 2025
The integral membrane protein smim4 modulates redox balance via malate compartmentalization in pancreatic cancer.

Bo Wang, Xinyu Han, Xianlong Lin

|May 16, 2024
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder.

Xiangshu Yuan, Ya Wang, Xiyuan Li

|Mar 24, 2023
Switching ubiquitous and muscle-specific isoforms of mitochondrial respiratory complex IV in skeletal muscle fine-tunes complex IV activity.

Xianglai Ye, Yaojun Xie, Yu Shi

|Apr 25, 2022
Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation.

Sixi Chen, Xinzhu Bao, Hongzhi Chen

|Mar 02, 2022
SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA.

Hezhi Fang, Anran Xie, Miaomiao Du

Pageof 2

Frequent Collaborators

2 joint publications

Qiongya Zhao

2 joint publications

Jianxin Lyu

2 joint publications

Wei Cui

1 joint publications

Jianxin Lyu